Comparison · NCT00088153-sae
Physiologic Estrogen Replacement vs Placebo: serious adverse events
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Physiologic Estrogen Replacement vs Placebo: serious adverse events. Trial comparisons, record NCT00088153-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00088153-sae
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.218 | 0.129 | 0.344 | wilson | |
| Risk in group 2 | 0.291 | 0.188 | 0.421 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0727 | -0.231 | 0.0898 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.75 | 0.392 | 1.43 | log | |
| Odds ratio, group 1 over group 2 | 0.68 | 0.286 | 1.62 | log | |
| Number needed to treat, for one fewer participant with a serious adverse event on Physiologic Estrogen Replacement than on Placebo | 13.8 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Physiologic Estrogen Replacement | Mature girls with anorexia nervosa (bone age 15 or greater): Transdermal estradiol (100 mcg) with cyclic progesterone (days 1-10 of each month).~Immature girls with anorexia nervosa (bone age less than 15 years): Ethinyl estradiol (3.75 mcg daily for the first 6 months, 7.5 mcg daily for the next 6 months, and 11.25 mcg daily for the final 6 months of the study | 12 | 55 | EG000 |
| Group 2 | Placebo | Mature girls with anorexia nervosa with a bone age of 15 years of greater: Placebo patches; Immature girls with anorexia nervosa with a bone age of less than 15 years: Placebo pills | 16 | 55 | EG001 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, serious adverse events
- Time frame
- 18 months for each subject(AN E+ versus AN E-)
Source ClinicalTrials.gov
Trial
- Title
- Effects of Anorexia Nervosa on Bone Mass in Adolescents
- NCT number
- NCT00088153
- Phases
- PHASE2, PHASE3
- Conditions
- Anorexia Nervosa
- Interventions
- Physiologic Estrogen/progesterone, Placebo
- Lead sponsor
- Massachusetts General Hospital
- Results first posted
- 2011-10-10
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT00088153?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT00088153-sae